Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK FOR FYSIOTERAPI FYSIOCENTER ROSKILDE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   5.7% 11.1% 3.8% 1.8% 1.4% 1.0% 4.5% 4.2%   Credit score (0-100)   42 23 51 70 78 85 47 48   Credit rating   BBB BB BBB A A A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 1.7 48.4 367.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   14,721 14,479 12,424 0 0 0 0 0   Gross profit   11,243 11,015 10,696 12,407 17,936 19,194 0.0 0.0   EBITDA   -53.6 800 480 980 2,898 3,520 0.0 0.0   EBIT   -114 710 347 240 938 1,337 0.0 0.0   Pre-tax profit (PTP)   -149.2 657.9 335.4 11.2 497.2 764.8 0.0 0.0   Net earnings   -116.5 513.2 256.5 -2.7 375.9 566.8 0.0 0.0   Pre-tax profit without non-rec. items   -149 658 335 11.2 497 765 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   306 357 646 3,739 3,255 2,349 0.0 0.0   Shareholders equity total   335 848 1,104 1,102 1,363 1,800 1,375 1,375   Interest-bearing liabilities   1,241 54.5 42.0 11,397 12,081 8,217 7,856 7,856   Balance sheet total (assets)   2,839 2,178 3,549 15,861 16,335 14,175 9,231 9,231   Net Debt   234 -267 -1,138 11,272 11,881 7,948 7,856 7,856     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   14,721 14,479 12,424 0 0 0 0 0   Net sales growth   -4.4% -1.6% -14.2% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,243 11,015 10,696 12,407 17,936 19,194 0.0 0.0   Gross profit growth   -7.1% -2.0% -2.9% 16.0% 44.6% 7.0% -100.0% 0.0%   Employees   14 12 12 28 35 33 0 0   Employee growth %   -6.7% -14.3% 0.0% 133.3% 25.0% -5.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,839 2,178 3,549 15,861 16,335 14,175 9,231 9,231   Balance sheet change%   28.6% -23.3% 63.0% 346.9% 3.0% -13.2% -34.9% 0.0%   Added value   -53.6 800.4 479.5 979.7 1,678.2 3,520.4 0.0 0.0   Added value %   -0.4% 5.5% 3.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   98 -40 157 11,870 -1,452 -4,366 -2,349 0   Net sales trend   -1.0 -2.0 -3.0 -4.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   -0.4% 5.5% 3.9% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   -0.8% 4.9% 2.8% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -1.0% 6.4% 3.2% 1.9% 5.2% 7.0% 0.0% 0.0%   Net Earnings %   -0.8% 3.5% 2.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -0.4% 4.2% 3.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -1.0% 4.5% 2.7% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -4.5% 28.3% 12.1% 2.5% 5.8% 8.8% 0.0% 0.0%   ROI %   -8.9% 57.3% 25.8% 3.2% 7.0% 11.2% 0.0% 0.0%   ROE %   -29.7% 86.8% 26.3% -0.2% 30.5% 35.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   11.8% 38.9% 31.1% 6.9% 8.3% 12.7% 14.9% 14.9%   Relative indebtedness %   17.0% 9.2% 19.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   10.2% 7.0% 10.2% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -436.7% -33.3% -237.4% 1,150.5% 409.9% 225.8% 0.0% 0.0%   Gearing %   370.6% 6.4% 3.8% 1,034.5% 886.2% 456.5% 571.3% 571.3%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.0% 8.0% 25.2% 4.0% 3.8% 5.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 1.3 1.6 0.4 0.8 0.5 0.0 0.0   Current Ratio   1.0 1.4 1.6 0.4 0.8 0.5 0.0 0.0   Cash and cash equivalent   1,006.5 321.1 1,180.3 125.7 200.7 268.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   32.6 31.4 38.8 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   21.7 16.9 19.5 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   17.1% 12.5% 23.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   18.5 481.0 1,094.9 -3,813.4 -624.1 -2,331.0 -3,928.0 -3,928.0   Net working capital %   0.1% 3.3% 8.8% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   1,052 1,207 1,035 0 0 0 0 0   Added value / employee   -4 67 40 35 48 107 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -4 67 40 35 83 107 0 0   EBIT / employee   -8 59 29 9 27 41 0 0   Net earnings / employee   -8 43 21 -0 11 17 0 0